• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Colgate Announces 1st Quarter 2026 Results

    5/1/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email

    Colgate-Palmolive Company (NYSE:CL):

    • Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales
    • GAAP EPS decreased 6% to $0.80; Base Business EPS* increased 7% to $0.97
    • GAAP Gross profit margin and Base Business Gross profit margin* decreased 20 basis points to 60.6%
    • Net cash provided by operations was $747 million for the first three months of 2026
    • The Company's leadership in toothpaste continued with its global market share at 41.1% year to date
    • The Company's leadership in manual toothbrushes continued with its global market share at 32.6% year to date
    • The Company maintained its sales and earnings per share guidance and updated its gross profit margin guidance for full year 2026

    First Quarter Total Company Results (GAAP)

    ($ in millions except per share amounts)

    2026

    2025

    Change

    Net Sales

    $5,324

    $4,911

    +8.4%

    EPS (diluted)

    $0.80

    $0.85

    -6%

     

     

     

     

     

     

     

     

    First Quarter Total Company Results (Base Business - Non-GAAP)*

     

    2026

    2025

    Change

    Organic Sales Growth

    +2.9%

    Base Business EPS (diluted)

    $0.97

    $0.91

    +7%

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Colgate-Palmolive Company (NYSE:CL) today reported results for first quarter 2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business first quarter results, "We delivered a strong start to 2026, with broad-based top and bottom-line growth. Net sales and organic sales grew in every category and in four of five divisions with a nice balance of volume and pricing growth. Gross profit margin increased sequentially versus fourth quarter 2025 and operating profit, net income, earnings per share and free cash flow all increased year over year along with an increase in advertising spending.

    "These results underscore the resilience of our business model as we are able to execute against our long-term strategy while delivering strong results in a difficult operating environment. While we expect the volatile macroeconomic conditions and slower category growth to continue in 2026, we are aligned behind our 2030 strategy to deliver consistent, compounded earnings per share growth and drive long-term shareholder value."

    Separately, building on the Company's successful implementation of the Strategic Growth and Productivity Program (the "SGPP") to date, on April 30, 2026, the Company's Board of Directors approved an expansion of the SGPP to continue to align the Company's operations to drive future growth and support the Company's 2030 strategy. The Company still expects substantially all of the charges to be incurred by December 31, 2028. As a result of the expansion, cumulative pretax charges related to the SGPP, once all projects are approved and implemented, are now estimated to be $350 million to $550 million, increased from $200 million to $300 million. Cumulative pretax savings are projected to be $200 million to $300 million, annually, once all projects are approved and implemented.

    Full Year 2026 Guidance

    Based on current spot rates and including the estimated impact of tariffs announced and finalized as of April 29, 2026:

    • The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.
    • The Company still expects organic sales growth to be 1% to 4%. This includes the impact from our exit from the private label pet food business.
    • On a GAAP basis, the Company now expects gross profit margin to be down (versus up previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.
    • On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be down (versus up previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also still expects low to mid-single-digit earnings per share growth.

    Divisional Performance

    See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.

    First Quarter Sales Growth By Division

    (% change 1Q 2026 vs. 1Q 2025 except % of Total Company Sales)

     

     

     

    % of Total

    Company

    Sales

    Net

    Sales

    Organic

    Sales*

    As

    Reported

    Volume**

    Pricing

    FX

    North America(1)

    17%

    -1.8%

    -2.2%

    -3.2%

    +1.0%

    +0.4%

    Latin America

    25%

    +14.8%

    +5.4%

    +2.0%

    +3.4%

    +9.5%

    Europe, Middle East & Africa(1)

    21%

    +11.9%

    +3.5%

    +2.2%

    +1.2%

    +8.5%

    Asia Pacific(1)

    15%

    +8.9%

    +5.6%

    +4.6%

    +1.0%

    +3.3%

    Hill's Pet Nutrition

    22%

    +6.7%

    +2.1%

    +0.2%

    +3.8%

    +2.7%

     

     

     

     

     

     

     

    Total Company

    100%

    +8.4%

    +2.9%

    +1.1%

    +2.2%

    +5.1%

    Note: Table may not sum due to rounding.

     

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. The results of the Europe and Africa/Eurasia (excluding Russia and Belarus) reportable operating segments and the skin health business (previously within the North America reportable operating segment) have been combined in a new Europe, Middle East & Africa reportable operating segment. In conjunction with this realignment, Russia and Belarus, which were previously reported within the Africa/Eurasia reportable operating segment, are now reported within the Asia Pacific reportable operating segment. Recast historical geographic segment information can be found on the Company's website.

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 5 - Geographic Sales Analysis Percentage Changes" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

     

    **The impact of the acquisition of the Prime100 pet food business on as reported volume was 1.9% and 0.4% for Hill's Pet Nutrition and Total Company, respectively.

    First Quarter Operating Profit By Division

    ($ in millions)

     

     

    1Q 2026

    % Change vs

    1Q 2025

    % to Net

    Sales

    Change in basis

    points vs 1Q 2025

    % to Net Sales

    North America(1)

    $141

    -28%

    15.8%

    -590

    Latin America

    $401

    15%

    30.6%

    +20

    Europe, Middle East & Africa(1)

    $266

    20%

    23.6%

    +160

    Asia Pacific(1)

    $222

    9%

    27.6%

    -10

    Hill's Pet Nutrition

    $280

    8%

    23.4%

    +30

     

     

     

     

     

    Total Company, As Reported

    $964

    -10%

    18.1%

    -380

    Total Company, Base Business*

    $1,134

    4%

    21.3%

    -90

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Prepared Materials and Webcast Information

    At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding first quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

    At 8:00 a.m. ET today, the Company will host a conference call regarding first quarter results. To access this call as a webcast, please go to Colgate-Palmolive's website at www.colgatepalmolive.com.

    About Colgate-Palmolive

    Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill's Prescription Diet, Hill's Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom's of Maine. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water and improving children's oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-E

    Market Share Information

    Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

    Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

    Cautionary Statement on Forward-Looking Statements

    This press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, category growth rates, the impact of foreign exchange, the impact of developments in global trade relations and tariffs, the impact of geopolitical events and tensions, wars and military conflicts, such as in Ukraine and the Middle East, cost reduction plans (including the Strategic Growth and Productivity Program), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made, except as otherwise noted with respect to tariffs, on the basis of the Company's views and assumptions as of May 1, 2026. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company's Investor Relations Department or on the Company's website at www.colgatepalmolive.com.

    Non-GAAP Financial Measures

    The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

    • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the Strategic Growth and Productivity Program and the ERISA litigation matter.
    • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
    • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

    This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company's underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See "Geographic Sales Analysis Percentage Changes" for the three months ended March 31, 2026 versus 2025 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

    Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company's business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company's underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See "Non-GAAP Reconciliations" for the three months ended March 31, 2026 and 2025 included with this release for a reconciliation of these financial measures to the related GAAP measures.

    The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

    As management uses free cash flow before dividends to evaluate the Company's ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See "Condensed Consolidated Statements of Cash Flows" for the three months ended March 31, 2026 and 2025 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

    (See attached tables for first quarter results.)

     

     

     

     

    Table 1

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Income

     

    For the Three Months Ended March 31, 2026 and 2025

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

    2026

     

    2025

     

     

     

     

     

    Net sales

     

    $

    5,324

     

     

    $

    4,911

     

     

     

     

     

     

    Cost of sales

     

     

    2,098

     

     

     

    1,924

     

     

     

     

     

     

    Gross profit

     

     

    3,226

     

     

     

    2,987

     

     

     

     

     

     

    Gross profit margin

     

     

    60.6

    %

     

     

    60.8

    %

     

     

     

     

     

    Selling, general and administrative expenses

     

     

    2,076

     

     

     

    1,898

     

     

     

     

     

     

    Other (income) expense, net

     

     

    186

     

     

     

    13

     

     

     

     

     

     

    Operating profit

     

     

    964

     

     

     

    1,076

     

     

     

     

     

     

    Operating profit margin

     

     

    18.1

    %

     

     

    21.9

    %

     

     

     

     

     

    Non-service related postretirement costs

     

     

    26

     

     

     

    72

     

     

     

     

     

     

    Interest expense

     

     

    62

     

     

     

    66

     

     

     

     

     

     

    Interest income

     

     

    16

     

     

     

    15

     

     

     

     

     

     

    Income before income taxes

     

     

    892

     

     

     

    953

     

     

     

     

     

     

    Provision for income taxes

     

     

    211

     

     

     

    227

     

     

     

     

     

     

    Effective tax rate

     

     

    23.6

    %

     

     

    23.7

    %

     

     

     

     

     

    Net income including noncontrolling interests

     

     

    681

     

     

     

    726

     

     

     

     

     

     

    Less: Net income attributable to noncontrolling interests

     

     

    35

     

     

     

    36

     

     

     

     

     

     

    Net income attributable to Colgate-Palmolive Company

     

    $

    646

     

     

    $

    690

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

    Basic

     

    $

    0.81

     

     

    $

    0.85

     

    Diluted

     

    $

    0.80

     

     

    $

    0.85

     

     

     

     

     

     

    Supplemental Income Statement Information

     

     

     

     

    Average common shares outstanding

     

     

     

     

    Basic

     

     

    802.3

     

     

     

    812.0

     

    Diluted

     

     

    805.1

     

     

     

    815.0

     

     

     

     

     

     

    Advertising

     

    $

    734

     

     

    $

    668

     

     

     

     

     

     

     

    Table 2

    Colgate-Palmolive Company

     

    Condensed Consolidated Balance Sheets

     

    As of March 31, 2026, December 31, 2025 and March 31, 2025

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

     

     

    March 31,

     

    December 31,

     

    March 31,

     

     

    2026

     

    2025

     

    2025

    Cash and cash equivalents

     

    $

    1,335

     

     

    $

    1,288

     

     

    $

    1,112

     

    Receivables, net

     

     

    1,889

     

     

     

    1,675

     

     

     

    1,725

     

    Inventories

     

     

    2,086

     

     

     

    2,032

     

     

     

    2,125

     

    Other current assets

     

     

    772

     

     

     

    714

     

     

     

    852

     

    Property, plant and equipment, net

     

     

    4,622

     

     

     

    4,660

     

     

     

    4,416

     

    Goodwill

     

     

    3,107

     

     

     

    3,122

     

     

     

    3,334

     

    Other intangible assets, net

     

     

    1,521

     

     

     

    1,536

     

     

     

    1,782

     

    Other assets

     

     

    1,278

     

     

     

    1,303

     

     

     

    1,301

     

    Total assets

     

    $

    16,610

     

     

    $

    16,330

     

     

    $

    16,647

     

     

     

     

     

     

     

     

    Total debt

     

    $

    7,973

     

     

    $

    7,988

     

     

    $

    8,269

     

    Other current liabilities

     

     

    5,898

     

     

     

    5,736

     

     

     

    5,163

     

    Other non-current liabilities

     

     

    2,253

     

     

     

    2,241

     

     

     

    2,482

     

    Total liabilities

     

     

    16,124

     

     

     

    15,965

     

     

     

    15,914

     

    Total Colgate-Palmolive Company shareholders' equity

     

     

    145

     

     

     

    54

     

     

     

    363

     

    Noncontrolling interests

     

     

    341

     

     

     

    311

     

     

     

    370

     

    Total liabilities and equity

     

    $

    16,610

     

     

    $

    16,330

     

     

    $

    16,647

     

     

     

     

     

     

     

     

    Supplemental Balance Sheet Information

     

     

     

     

     

     

    Debt less cash, cash equivalents and marketable securities(1)

     

    $

    6,554

     

     

    $

    6,593

     

     

    $

    6,958

     

    Working capital % of sales

     

     

    (5.7

    )%

     

     

    (7.0

    )%

     

     

    (3.3

    )%

    Note:

    (1) Marketable securities of $84, $107 and $199 as of March 31, 2026, December 31, 2025 and March 31, 2025, respectively, are included in Other current assets.

     

     

     

     

    Table 3

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Cash Flows

     

    For the Three Months Ended March 31, 2026 and 2025

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

    2026

     

    2025

    Operating Activities

     

     

     

     

    Net income including noncontrolling interests

     

    $

    681

     

     

    $

    726

     

    Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:

     

     

    Depreciation and amortization

     

     

    156

     

     

     

    148

     

    ERISA litigation matter

     

     

    —

     

     

     

    65

     

    Restructuring and termination benefits, net of cash

     

     

    165

     

     

     

    (7

    )

    Stock-based compensation expense

     

     

    40

     

     

     

    23

     

    Deferred income taxes

     

     

    (18

    )

     

     

    (24

    )

    Cash effects of changes in:

     

     

     

     

    Receivables

     

     

    (215

    )

     

     

    (174

    )

    Inventories

     

     

    (41

    )

     

     

    (86

    )

    Accounts payable and other working capital

     

     

    (11

    )

     

     

    (57

    )

    Other non-current assets

     

     

    19

     

     

     

    (1

    )

    Other non-current liabilities

     

     

    (29

    )

     

     

    (13

    )

    Net cash provided by (used in) operations

     

     

    747

     

     

     

    600

     

     

     

     

     

     

    Investing Activities

     

     

     

     

    Capital expenditures

     

     

    (138

    )

     

     

    (124

    )

    Purchases of marketable securities and investments

     

     

    (70

    )

     

     

    (134

    )

    Proceeds from sale of marketable securities and investments

     

     

    94

     

     

     

    97

     

    Other investing activities

     

     

    (8

    )

     

     

    2

     

    Net cash provided by (used in) investing activities

     

     

    (122

    )

     

     

    (159

    )

     

     

     

     

     

    Financing Activities

     

     

     

     

    Short-term borrowing (repayment) less than 90 days, net

     

     

    1,138

     

     

     

    164

     

    Principal payments on debt

     

     

    (1,082

    )

     

     

    (4

    )

    Proceeds from issuance of debt

     

     

    —

     

     

     

    —

     

    Dividends paid

     

     

    (417

    )

     

     

    (406

    )

    Purchases of treasury shares

     

     

    (306

    )

     

     

    (284

    )

    Proceeds from exercise of stock options

     

     

    127

     

     

     

    40

     

    Other financing activities

     

     

    (23

    )

     

     

    32

     

    Net cash provided by (used in) financing activities

     

     

    (563

    )

     

     

    (458

    )

     

     

     

     

     

    Effect of exchange rate changes on Cash and cash equivalents

     

     

    (15

    )

     

     

    33

     

    Net increase (decrease) in Cash and cash equivalents

     

     

    47

     

     

     

    16

     

    Cash and cash equivalents at beginning of the period

     

     

    1,288

     

     

     

    1,096

     

    Cash and cash equivalents at end of the period

     

    $

    1,335

     

     

    $

    1,112

     

     

     

     

     

     

    Supplemental Cash Flow Information

     

     

     

     

    Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

     

     

     

     

    Net cash provided by operations

     

    $

    747

     

     

    $

    600

     

    Less: Capital expenditures

     

     

    (138

    )

     

     

    (124

    )

    Free cash flow before dividends

     

    $

    609

     

     

    $

    476

     

     

     

     

     

     

     

     

     

     

     

    Income taxes paid

     

    $

    176

     

     

    $

    139

     

    Interest paid

     

    $

    96

     

     

    $

    109

     

     

     

     

     

    Table 4

    Colgate-Palmolive Company

     

    Segment Information

     

    For the Three Months Ended March 31, 2026 and 2025

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2026

     

    2025

    Net Sales

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    888

     

     

    $

    904

     

    Latin America

     

     

    1,313

     

     

     

    1,143

     

    Europe, Middle East & Africa(1)

     

     

    1,126

     

     

     

    1,007

     

    Asia Pacific(1)

     

     

    804

     

     

     

    738

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    4,131

     

     

     

    3,792

     

     

     

     

     

     

    Pet Nutrition

     

     

    1,194

     

     

     

    1,118

     

     

     

     

     

     

    Total Net Sales

     

    $

    5,324

     

     

    $

    4,911

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2026

     

    2025

    Operating Profit

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    141

     

     

    $

    197

     

    Latin America

     

     

    401

     

     

     

    348

     

    Europe, Middle East & Africa(1)

     

     

    266

     

     

     

    222

     

    Asia Pacific(1)

     

     

    222

     

     

     

    204

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    1,030

     

     

     

    971

     

     

     

     

     

     

    Pet Nutrition

     

     

    280

     

     

     

    258

     

    Corporate(2)

     

     

    (346

    )

     

     

    (153

    )

     

     

     

     

     

    Total Operating Profit

     

    $

    964

     

     

    $

    1,076

     

    Tables may not sum due to rounding.

     

    Notes:

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

     

    (2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

     

    Corporate Operating profit (loss) for the three months ended March 31, 2026 included charges resulting from the Strategic Growth and Productivity Program of $171.

     

    Corporate Operating profit (loss) for the three months ended March 31, 2025 included charges resulting from the ERISA litigation matter of $15.

    Table 5

    Colgate-Palmolive Company

     

    Geographic Sales Analysis Percentage Changes

     

    For the Three Months Ended March 31, 2026 vs. 2025

     

    (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    COMPONENTS OF SALES CHANGE

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Pricing

     

     

     

     

     

     

     

     

     

     

     

     

    Coupons

     

     

     

     

    Sales

     

     

     

     

     

     

     

    Consumer &

     

     

     

     

    Change

     

    Organic

     

    As Reported

     

    Organic

     

    Trade

     

    Foreign

    Region

     

    As Reported

     

    Sales Change

     

    Volume(1)

     

    Volume

     

    Incentives

     

    Exchange

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total Company

     

    8.4

    %

     

    2.9

    %

     

    1.1

    %

     

    0.6

    %

     

    2.2

    %

     

    5.1

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America(2)

     

    (1.8

    )%

     

    (2.2

    )%

     

    (3.2

    )%

     

    (3.2

    )%

     

    1.0

    %

     

    0.4

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Latin America

     

    14.8

    %

     

    5.4

    %

     

    2.0

    %

     

    2.0

    %

     

    3.4

    %

     

    9.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe, Middle East & Africa(2)

     

    11.9

    %

     

    3.5

    %

     

    2.2

    %

     

    2.2

    %

     

    1.2

    %

     

    8.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Asia Pacific(2)

     

    8.9

    %

     

    5.6

    %

     

    4.6

    %

     

    4.6

    %

     

    1.0

    %

     

    3.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total CP Products

     

    8.9

    %

     

    3.1

    %

     

    1.3

    %

     

    1.3

    %

     

    1.8

    %

     

    5.9

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Hill's Pet Nutrition

     

    6.7

    %

     

    2.1

    %

     

    0.2

    %

     

    (1.7

    )%

     

    3.8

    %

     

    2.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Emerging Markets(3)

     

    12.9

    %

     

    6.2

    %

     

    3.5

    %

     

    3.5

    %

     

    2.7

    %

     

    6.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Developed Markets

     

    4.9

    %

     

    0.2

    %

     

    (0.9

    )%

     

    (1.7

    )%

     

    1.9

    %

     

    3.9

    %

    Table may not sum due to rounding.

     

    Notes:

    (1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.4%, 1.9% and 0.8% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

     

    (2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

     

    (3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe.

    Table 6

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended March 31, 2026 and 2025

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, General and Administrative Expenses

    2026

     

    2025

     

     

    Selling, general and administrative expenses, GAAP

    $

    2,076

     

     

    $

    1,898

     

     

     

    Strategic Growth and Productivity Program

     

    (6

    )

     

     

    —

     

     

     

    ERISA litigation matter

     

    —

     

     

     

    (15

    )

     

     

    Selling, general and administrative expenses, non-GAAP

    $

    2,071

     

     

    $

    1,883

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Selling, General and Administrative Expenses as a Percentage of Net Sales

    2026

     

    2025

     

    Change

    Selling, general and administrative expenses as a percentage of Net sales, GAAP

     

    39.0

    %

     

     

    38.6

    %

     

    40

     

    Strategic Growth and Productivity Program

     

    (0.1

    )%

     

     

    —

    %

     

     

    ERISA litigation matter

     

    —

    %

     

     

    (0.3

    )%

     

     

    Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

     

    38.9

    %

     

     

    38.3

    %

     

    60

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Other (Income) Expense, Net

    2026

     

    2025

     

     

    Other (income) expense, net, GAAP

    $

    186

     

     

    $

    13

     

     

     

    Strategic Growth and Productivity Program

     

    (165

    )

     

     

    —

     

     

     

    Other (income) expense, net, non-GAAP

    $

    21

     

     

    $

    13

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Profit

     

    2026

     

    2025

     

    % Change

    Operating profit, GAAP

     

    $

    964

     

     

    $

    1,076

     

     

    (10

    )%

    Strategic Growth and Productivity Program

     

    171

     

     

     

    —

     

     

     

    ERISA litigation matter

     

     

    —

     

     

     

    15

     

     

     

    Operating profit, non-GAAP

     

    $

    1,134

     

     

    $

    1,091

     

     

    4

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Operating Profit Margin

    2026

     

    2025

     

    Change

    Operating profit margin, GAAP

     

    18.1

    %

     

     

    21.9

    %

     

    (380

    )

    Strategic Growth and Productivity Program

     

    3.2

    %

     

     

    —

    %

     

     

    ERISA litigation matter

     

     

    —

    %

     

     

    0.3

    %

     

     

    Operating profit margin, non-GAAP

     

    21.3

    %

     

     

    22.2

    %

     

    (90

    )

     

     

     

     

     

     

     

     

    Non-Service Related Postretirement Costs

    2026

     

    2025

     

     

    Non-service related postretirement costs, GAAP

    $

    26

     

     

    $

    72

     

     

     

    Strategic Growth and Productivity Program

     

    (5

    )

     

     

    —

     

     

     

    ERISA litigation matter

     

     

    —

     

     

     

    (50

    )

     

     

    Non-service related postretirement costs, non-GAAP

    $

    20

     

     

    $

    22

     

     

     

     

     

     

     

     

     

     

    Note: The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

    Table 6

    Continued

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended March 31, 2026 and 2025

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

    2026

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    892

     

    $

    211

     

    $

    681

     

    $

    35

     

    $

    646

     

    23.6

    %

     

    $

    0.80

    Strategic Growth and Productivity

    Program

     

    176

     

     

    37

     

     

    139

     

     

    1

     

     

    138

     

    (0.4

    )%

     

     

    0.17

    Non-GAAP

    $

    1,068

     

    $

    248

     

    $

    820

     

    $

    36

     

    $

    784

     

    23.2

    %

     

    $

    0.97

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2025

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    953

     

    $

    227

     

    $

    726

     

    $

    36

     

    $

    690

     

    23.7

    %

     

    $

    0.85

    ERISA litigation matter

     

    65

     

     

    12

     

     

    53

     

     

    —

     

     

    53

     

    (0.3

    )%

     

     

    0.06

    Non-GAAP

    $

    1,018

     

    $

    239

     

    $

    779

     

    $

    36

     

    $

    743

     

    23.4

    %

     

    $

    0.91

    The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

     

    Notes:

    (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

     

    (2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260501892320/en/

    Investor Relations: investor_relations@colpal.com

    Communications: colgate_palmolive_media_inquiry@colpal.com

    Get the next $CL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    4/21/2026$100.00Neutral → Buy
    Rothschild & Co Redburn
    3/31/2026$85.00Buy → Hold
    TD Cowen
    3/30/2026$98.00Hold → Buy
    Deutsche Bank
    1/13/2026$86.00Underweight → Equal Weight
    Wells Fargo
    1/7/2026$88.00Neutral → Overweight
    Piper Sandler
    12/11/2025Buy → Hold
    Argus
    12/9/2025$88.00Sector Perform → Outperform
    RBC Capital Mkts
    10/3/2025$84.00Neutral
    Piper Sandler
    More analyst ratings

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference

    Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant and Executive Vice President, M&A and Special Projects, John Faucher will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on Wednesday, June 3, 2026 at 8:45 am ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets an

    5/20/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Announces 1st Quarter 2026 Results

    Colgate-Palmolive Company (NYSE:CL): Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales GAAP EPS decreased 6% to $0.80; Base Business EPS* increased 7% to $0.97 GAAP Gross profit margin and Base Business Gross profit margin* decreased 20 basis points to 60.6% Net cash provided by operations was $747 million for the first three months of 2026 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.6% year to date The Company maintained its sales and earnings

    5/1/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Announces Webcast of its 2026 First Quarter Earnings Conference Call May 1, 2026 - Now at 8:00 a.m. ET and its 2026 Annual Meeting of Stockholders on May 8, 2026 at 10:00 a.m. ET

    Due to a scheduling conflict, Colgate-Palmolive Company (NYSE:CL) will now provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:00 a.m. ET (previously 8:30 a.m. ET). The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded

    4/27/26 3:44:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded Colgate-Palmolive from Neutral to Buy and set a new price target of $100.00

    4/21/26 7:27:56 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by TD Cowen with a new price target

    TD Cowen downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $85.00

    3/31/26 8:07:24 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Colgate-Palmolive from Hold to Buy and set a new price target of $98.00

    3/30/26 8:11:51 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Controller Malcolm Gregory sold $203,412 worth of shares (2,300 units at $88.44), decreasing direct ownership by 14% to 13,598 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    5/18/26 4:06:19 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Hundmejean Martina was granted 2,075 shares, increasing direct ownership by 15% to 16,206 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    5/13/26 4:46:47 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Newman Brian was granted 2,075 shares, increasing direct ownership by 37% to 7,621 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    5/13/26 4:46:51 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    SEC Filings

    View All

    SEC Form SD filed by Colgate-Palmolive Company

    SD - COLGATE PALMOLIVE CO (0000021665) (Filer)

    6/1/26 4:01:52 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    5/13/26 4:02:15 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form DEFA14A filed by Colgate-Palmolive Company

    DEFA14A - COLGATE PALMOLIVE CO (0000021665) (Filer)

    4/16/26 4:06:39 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    View All

    Colgate Announces 1st Quarter 2026 Results

    Colgate-Palmolive Company (NYSE:CL): Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales GAAP EPS decreased 6% to $0.80; Base Business EPS* increased 7% to $0.97 GAAP Gross profit margin and Base Business Gross profit margin* decreased 20 basis points to 60.6% Net cash provided by operations was $747 million for the first three months of 2026 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.6% year to date The Company maintained its sales and earnings

    5/1/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Announces Webcast of its 2026 First Quarter Earnings Conference Call May 1, 2026 - Now at 8:00 a.m. ET and its 2026 Annual Meeting of Stockholders on May 8, 2026 at 10:00 a.m. ET

    Due to a scheduling conflict, Colgate-Palmolive Company (NYSE:CL) will now provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:00 a.m. ET (previously 8:30 a.m. ET). The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded

    4/27/26 3:44:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2026 First Quarter Earnings Conference Call May 1, 2026 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the In

    4/17/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    View All

    Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

    2/10/25 6:30:00 AM ET
    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

    Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

    1/3/23 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/13/24 5:02:36 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/23 11:15:26 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/22 3:43:30 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary